Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease [NA]

View source ↗

Summary

A clinical trial comparing BUFY02 versus TRB02 for Dry Eye Disease is currently recruiting, with no results reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUFY02
  • TRB02

Snippet

Sponsor: TRB Chemedica International SA | Conditions: Dry Eye Disease | NA | Status: RECRUITING